Search for: "Sanofi US Corporation"
Results 81 - 100
of 103
Sorted by Relevance
|
Sort by Date
22 Feb 2008, 6:00 pm
: (GenericsWeb),US: Dr Robert Shapiro discusses follow-on biologics report: (Patent Docs),US: New report identifies $387 billion in savings from generic biologics: (Holman's Biotech IP Blog),US: Can approval of biogenerics really save money? [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
28 Apr 2008, 11:00 am
: (Spicy IP), US: Who’s to blame for rising drug prices? [read post]
1 May 2017, 11:36 am
It provides us freedom to do what we need to do to have a sustainable innovation policy and bring wealth and wellbeing to Canadians. [read post]
1 May 2017, 11:36 am
It provides us freedom to do what we need to do to have a sustainable innovation policy and bring wealth and wellbeing to Canadians. [read post]
10 May 2011, 1:29 pm
" Sanofi-Synthelabo v. [read post]
5 Dec 2022, 1:03 pm
Sanofi U.S. [read post]
9 Jun 2012, 5:13 am
Smith Corporation) on March 28, 2012 discussing the need to take reasonable measures to protect information that you wish to protect as a trade secret. [read post]
26 Oct 2022, 3:17 am
When an advertisement makes claims about a product or service, that claim may be crucial to a consumer’s decision to buy or use that product or service. [read post]
16 May 2008, 8:03 am
– Brdo: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 16 June / 1 July:US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - San Francisco / New York: (Patent Docs), 17-20 June: US BIO international convention – San Diego: (Patent Docs), 18-20 June / 9-11 July: US PLI: ‘Fundamentals of… [read post]
24 Feb 2022, 6:12 pm
One more is still pending – Intel Corporation v. [read post]
6 May 2021, 3:02 am
And Jack Thompson, Assistant Director of Global eDiscovery and Legal Operations at Sanofi, who, by the way, is not a lawyer, said that he prefers to see substance or quality of work, not the credentials or degrees of an individual providing expertise and knowledge. [read post]
2 Nov 2009, 1:24 pm
" Savage notes that the case is emblematic of a "long-running war" between California prosecutors and the Ninth Circuit over the use of death sentences in the state. [read post]
29 May 2009, 1:28 am
Visit International News
Technology Is Great, but Prove Your Point
The Recorder
The use of trial technology has exploded. [read post]
6 Jan 2015, 4:14 am
However, an interesting new initiative has recently emerged – the attempt to achieve litigation reform through amendments to corporate bylaws. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
13 Apr 2014, 8:59 am
Sanofi-Synthelabo Canada Inc., [2008] 3 SCR 265 At the outset, it is appropriate to refer to the words of Judson J. for this Court in Commissioner of Patents v. [read post]
31 Dec 2015, 5:12 am
Sanofi-Aventis United States LLP, 806 F.3d 71 (2d Cir. 2015). [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies… [read post]
15 Mar 2007, 2:12 am
A number of disputes relating to newly merged or collaborating corporations were also filed. [read post]
